Bioneercorporation바이오니아
064550 · KOSDAQ · ₩064550 · 바이오니아
₩7,070▲ ₩60 (0.86%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩330B | ₩294B | ₩263B | ₩218B | ₩224B |
| Cost of sales | ₩73B | ₩74B | ₩60B | ₩52B | ₩50B |
| Gross profit | ₩257B | ₩220B | ₩203B | ₩167B | ₩174B |
| Operating income | ₩15B | −₩13B | ₩792M | ₩12B | ₩47B |
| Net income | ₩1.7B | −₩19B | −₩6.9B | ₩15B | ₩29B |
| Net income to shareholders | −₩2.8B | −₩21B | −₩11B | ₩12B | ₩27B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩370B | ₩332B | ₩315B | ₩299B | ₩262B |
| Current assets | ₩149B | ₩149B | ₩148B | ₩134B | ₩136B |
| Cash and equivalents | ₩48B | ₩40B | ₩49B | ₩44B | ₩49B |
| Total liabilities | ₩143B | ₩105B | ₩81B | ₩55B | ₩55B |
| Current liabilities | ₩66B | ₩66B | ₩54B | ₩36B | ₩51B |
| Borrowings | ₩44B | ₩30B | ₩42B | ₩26B | ₩20B |
| Total equity | ₩227B | ₩227B | ₩235B | ₩244B | ₩208B |
| Shareholders' equity | ₩210B | ₩214B | ₩224B | ₩236B | ₩203B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩10B | −₩13B | ₩4.1B | ₩8.8B | ₩53B |
| Capital spending | ₩6.8B | ₩13B | ₩4.7B | ₩17B | ₩42B |
| Free cash flow | ₩3.5B | −₩26B | −₩524M | −₩8.7B | ₩11B |
Consolidated where available. Amounts in won.
Also known as: Bioneercorporation / 바이오니아 / 064550 / KRX:064550
Source: KRX statistical information